Name | 2-(4-methylphenyl)-5,6,7,8-tetrahydroimidazo[2,1-b][1,3]benzothiazole |
---|---|
Synonyms |
Pifithrin-Beta
UNII-45I8QO7K37 Pifithrin-β |
Description | Pifithrin-β is a potent p53 inhibitor with an IC50 of 23 μM. |
---|---|
Related Catalog | |
Target |
IC50: 23 μM (p53)[1] |
In Vitro | Pifithrin-α, an inhibitor of the p53 protein, is regarded as a lead compound for cancer and neurodegenerative disease therapy. Pifithrin-α is very unstable in culture medium and rapidly converts to its condensation product pifithrin-β, the N-acetyl derivative[2]. After 24 h, the viability assay shows that the pretreatments with 1 and 10 μM pifithrin-β exerts neuroprotective effects[3]. |
References |
Molecular Formula | C16H16N2S |
---|---|
Molecular Weight | 268.37700 |
Exact Mass | 268.10300 |
PSA | 45.54000 |
LogP | 4.25000 |
Storage condition | 2-8℃ |